AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 2 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,418,000 | +78.2% | 40,400 | -16.4% | 0.00% | +50.0% |
| Q3 2019 | $1,357,000 | -20.4% | 48,300 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $1,704,000 | +16.8% | 45,000 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $1,459,000 | +116.5% | 37,400 | +18.4% | 0.00% | +100.0% |
| Q4 2018 | $674,000 | -52.3% | 31,600 | -11.5% | 0.00% | -50.0% |
| Q3 2018 | $1,413,000 | +3.6% | 35,700 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,364,000 | +104.5% | 35,700 | +60.8% | 0.00% | +100.0% |
| Q1 2018 | $667,000 | +30.0% | 22,200 | +35.4% | 0.00% | 0.0% |
| Q4 2017 | $513,000 | +11.8% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $459,000 | +46.2% | 16,400 | 0.0% | 0.00% | – |
| Q2 2017 | $314,000 | +348.6% | 16,400 | +299.9% | 0.00% | – |
| Q1 2017 | $70,000 | +100.0% | 4,101 | +115.8% | 0.00% | – |
| Q4 2016 | $35,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $50,862,321,000 | 38.71% |
| Casdin Capital, LLC | 400,000 | $11,204,000 | 3.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,525,410 | $42,727,000 | 1.92% |
| Opaleye Management Inc. | 180,000 | $5,041,000 | 1.78% |
| Redmile Group, LLC | 1,289,332 | $36,114,000 | 1.78% |
| Cormorant Asset Management, LP | 323,545 | $9,062,000 | 1.60% |
| Orbimed Advisors | 4,129,638 | $115,671,000 | 1.10% |
| Perceptive Advisors | 1,562,618 | $43,770,000 | 0.84% |
| Rock Springs Capital Management LP | 525,000 | $14,705,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,661,000 | 0.38% |